
Progression-Free Survival vs. Overall Survival
When we evaluate new drugs in oncology, we, of course, want to determine their impact on survival or its converse, mortality. But there are various
When we evaluate new drugs in oncology, we, of course, want to determine their impact on survival or its converse, mortality. But there are various
My wife and I recently attended a wedding and ended up sitting next to my good friend Earl, an ophthalmologist, who said he reads my
In this time of war and problems domestically, we should highlight one ray of hope in the cancer arena, a new therapeutic approach with broad-based
I have been an early riser for years and decided years ago to take advantage of this and go to work early. As a consequence,
Today is Elie’s birthday and, while Elie does not usually care about gifts, I do feel bad that I did not get her anything. As
As a medical student, one of the things in which we reveled was eponyms. These are the names that are given to clinical signs, symptoms
Not long after I joined the faculty as an oncologist, I had a patient with advanced breast cancer. The main chemotherapy drug we used at
My mother died when I was 8 years old and consequently I have always had an inordinate fascination with death and its trappings. I often
I was lucky enough to attend the 1987 annual meeting of the American Society of Clinical Oncology when Charles Moertel delivered the annual Karnofsky Memorial
I recently finished reading a marvelous book by David Grann, “The Wager.” It recounts the story of the Wager, a British man-of-war in the 1740s
OK, I confess—I am a television addict—always have been and always will be. And one of my favorite shows is “Law & Order.” In 1994,
Measurement is central to science and medicine, and therefore any imprecision in this critical function can obscure our analyses and interventions. This issue applies to